Key market opportunities in dissolution testing include optimizing drug bioavailability and enhancing quality control to meet regulatory demands. Understanding scientific principles and regulatory ...
The Food and Drug Administration has initiated a Class II recall of 141,984 bottles of atorvastatin calcium after tests ...
Pharmaceutical Dissolution Market Pharmaceutical Dissolution Market Dublin, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The ...
The most popularly prescribed drug in the U.S. has been recalled by the Federal Drug Administration. Over 141,000 bottles of ...
Pharmacist and PhD researcher Hannah Cleary tells us about her work on long-acting injectables (LAIs) to improve drug ...
Teva issued a voluntary recall for two lots of its hypertension drug Matzim LA (diltiazem hydrochloride) after testing found the extended-release tablets failed to dissolve correctly. The recalled ...
A major recall is underway for over 140,000 bottles of Atorvastatin Calcium Tablets. This popular cholesterol medication, the ...
12d
FDA recalls over 140,000 bottles of cholesterol medication for 'failed dissolution specifications'
According to the FDA, 141,984 bottles of the 10mg medication were involved in the recall. The organization did not list ...
Health and Me on MSN
Popular Cholesterol Drug Recalled For Failing 'Dissolution Specifications', What Does This Mean?
Over 141,000 bottles of Atorvastatin Calcium Tablets, a widely used cholesterol medication, have been recalled in the U.S. after failing a “dissolution test,” which checks how well a drug dissolves in ...
Daily Voice Union County, NJ on MSN
Major Recall Issued For Top-Selling Cholesterol Drug In US
A drug taken daily by millions of Americans has been recalled nationwide after federal regulators said it failed quality ...
The FDA recalls over 140,000 bottles of Atorvastatin after failed quality tests. Find out which products are affected and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback